Search for: "Shire Development, LLC v. Watson Pharmaceuticals, Inc."
Results 1 - 8
of 8
Sorted by Relevance
|
Sort by Date
9 Apr 2014, 9:59 pm
Watson Pharmaceuticals, Inc., which doesn't... [read post]
14 Feb 2017, 9:13 pm
The lawsuit involved Watson's ANDA filing seeking approval for a generic version of Shire's controlled-release oral pharmaceutical composition for the treatment of inflammatory bowel disease, Crohn's disease, and ulcerative colitis, sold by Shire under the brand name LIALDA®. [read post]
15 Feb 2017, 2:49 pm
€ 160 The post USA: Shire Development, LLC v. [read post]
28 Jan 2015, 10:00 pm
On January 26, 2015, the Supreme Court granted certiorari, vacated, and remanded Shire Development LLC v. [read post]
23 May 2014, 6:08 pm
Shire Development, LLC at *2 (text added). [read post]
5 May 2010, 4:46 am
Watson Pharmaceuticals, Inc. et al. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on… [read post]
17 Jul 2017, 4:20 pm
Shire Development LLC v. [read post]
